An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice

References

• TC Marrs. (1993). Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• M Lotti. Organophosphorus compounds. In: PS Spencer, and HH Schaumburg. eds. Experimental and Clinical Neurotoxicology. New York: Oxford University Press; (2000): 898–925.
   Google Scholar
• RM Dawson. (1994). Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317–331.
   PubMed Web of Science ®Google Scholar
• P Taylor. Anticholinesterase agents. In: JG Hardman, and LE Limbird. eds. The Pharmacological Basis of Therapeutics. New York: McGraw Hill; (1996): 161–176.
   Google Scholar
• TM Shih. (1993). Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity. Arch Toxicol 67:637–646.
   PubMed Web of Science ®Google Scholar
• F Worek, M Backer, H Thiermann, L Szinicz, U Mast, R Klimmek, and P Eyer. (1997). Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16:466–472.
   PubMed Web of Science ®Google Scholar
• J Kassa. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• J Bajgar. (2004). Organophosphate/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• K Musilek, O Holas, D Jun, V Dohnal, F Gunn-Moore, V Opletalova, M Dolezal, and K Kuca. (2007). Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker – preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 15:6733–6741.
   PubMed Web of Science ®Google Scholar
• K Musilek, O Holas, K Kuca, D Jun, V Dohnal, V Opletalova, and M Dolezal. (2008). Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 23:70–76. doi: 10.1080/14756360701383981.
   PubMed Web of Science ®Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41–45.
   PubMedGoogle Scholar
• R Tallarida, and R Murray. Manual of Pharmacological Calculation with Computer Programs. New York: Springer-Verlag; (1987).
   Google Scholar
• JG Clement, AS Hansen, and CA Boulet. (1992). Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66:216–219.
   PubMed Web of Science ®Google Scholar
• GL Ellman, DK Courtney, V AndresJr, and RM Featherstone. (1961). A new and rapid determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–93. 1961
   PubMed Web of Science ®Google Scholar
• K Kuca, D Jun, and K Musilek. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 6:269–277.
   PubMed Web of Science ®Google Scholar
• K Kuca, V Racakova, D Jun, and J Bajgar. (2007). Structure-activity relationship of acetylcholinesterase reactivators – antidotes against nerve agents. Lett Org Chem 4:212–217.
   Web of Science ®Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 18:560–565.
   PubMed Web of Science ®Google Scholar
• K Kuca, D Jun, and J Bajgar. (2007). Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem Toxicol 30:31–40.
   PubMed Web of Science ®Google Scholar
• F Worek, R Widmann, O Knopff, and L Szinicz. (1998). Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237–243.
   PubMed Web of Science ®Google Scholar
• K Kuca, K Musilek, M Paar, D Jun, P Stodulka, M Hrabinova, and J Marek. (2007). Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridinium propane dibromide – a new nerve agent reactivator. Molecules 12:1964–1972.
   PubMed Web of Science ®Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111–118.
   PubMed Web of Science ®Google Scholar
• K Kuca, J Cabal, D Jun, J Kassa, L Bartosova, and G Kunesova. (2005). In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J Appl Toxicol 25:296–300.
   PubMed Web of Science ®Google Scholar
• J Kuca, and J Patocka. (2004). Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enzyme Inhib Med Chem 19:39–43.
   PubMed Web of Science ®Google Scholar
• K Kuca, J Cabal, and J Kassa. (2004). A comparison of the efficacy of a bispyridinium oxime – 1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Pharmazie 59:795–798.
   PubMed Web of Science ®Google Scholar
• J Kassa, K Kuca, L Bartosova, and G Kunesova. (2007). The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Cur Org Chem 11:267–283.
   Web of Science ®Google Scholar
• J Kassa, J Karasova, J Bajgar, K Kuca, and K Musilek. (2008). A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice. J Enzyme Inhib Med Chem doi: 10.1080/14756360701809902.
   PubMed Web of Science ®Google Scholar